Published in J Neurovirol on February 01, 2003
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
Retrotransposon-derived elements in the mammalian genome: a potential source of disease. J Inherit Metab Dis (2004) 1.20
Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol (2012) 1.04
Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One (2012) 0.97
The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity. PLoS One (2013) 0.90
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci (2007) 0.89
Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J Neural Transm (Vienna) (2007) 0.88
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages. Front Immunol (2015) 0.80
An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases. J R Soc Med (2009) 0.79
Human endogenous retroviruses in multiple sclerosis: potential for novel neuro-pharmacological research. Curr Neuropharmacol (2011) 0.77
The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis. PLoS One (2017) 0.75
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology. Viruses (2017) 0.75
Primary breast lymphoma - a review of the literature and report of three cases. Arch Med Sci (2011) 1.43
Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet (2011) 1.12
Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study. Br J Haematol (2008) 1.00
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). J Clin Oncol (2010) 0.99
Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood (2002) 0.93
I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res Treat (2007) 0.92
Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis. Pediatr Blood Cancer (2011) 0.92
Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia. BMC Cancer (2013) 0.91
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur J Gastroenterol Hepatol (2003) 0.90
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib. Eur J Haematol (2011) 0.88
Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur J Cancer (2008) 0.88
Comparative proteome analysis of acute myeloid leukemia with and without maturation. J Proteomics (2012) 0.87
Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma. Ann Hematol (2007) 0.87
Evaluation and comparison of random amplification of polymorphic DNA, pulsed-field gel electrophoresis and ADSRRS-fingerprinting for typing Serratia marcescens outbreaks. FEMS Immunol Med Microbiol (2003) 0.86
Evaluation of a novel method based on amplification of DNA fragments surrounding rare restriction sites (ADSRRS fingerprinting) for typing strains of vancomycin-resistant Enterococcus faecium. J Microbiol Methods (2003) 0.85
Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions. Mutagenesis (2011) 0.85
Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene. J Appl Genet (2008) 0.85
MSRV pol sequence copy number as a potential marker of multiple sclerosis. Pol J Pharmacol (2004) 0.84
Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase. Oncol Rep (2006) 0.84
Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Jpn J Infect Dis (2007) 0.84
Molecular genetics of Alzheimer's disease: presenilin 1 gene analysis in a cohort of patients from the Poznań region. J Appl Genet (2003) 0.83
Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1). Med Sci Monit (2005) 0.83
Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children? J Pediatr Hematol Oncol (2011) 0.82
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls. Gynecol Endocrinol (2010) 0.81
Genetic investigation of biological materials from patients after stem cell transplantation based on autosomal as well as Y-chromosomal markers. Int J Legal Med (2012) 0.80
Transmigration of blood leukocytes into the peritoneal cavity is related to the upregulation of ICAM-1 (CD54) and Mac-1 (CD11b/CD18) adhesion molecules. Perit Dial Int (2004) 0.80
The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats. Biopharm Drug Dispos (2014) 0.80
Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2. Mol Biol Rep (2013) 0.79
Frequency and molecular characteristics of calreticulin gene (CALR) mutations in patients with JAK2 -negative myeloproliferative neoplasms. Acta Haematol (2014) 0.79
Cancer procoagulant in patients with adenocarcinomas. Blood Coagul Fibrinolysis (2005) 0.79
Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG). Ann Hematol (2006) 0.78
Blood-brain barrier breakdown and cerebellar degeneration in the course of experimental neoplastic disease. Are circulating Cytokine-Induced Neutrophil Chemoattractant-1 (CINC-1) and -2alpha(CINC-2alpha) the involved mediators? Folia Neuropathol (2010) 0.78
Lack of correlation between telomere length and telomerase activity and expression in leukemic cells. Int J Mol Med (2003) 0.77
Comparative proteomics in acute myeloid leukemia. Contemp Oncol (Pozn) (2012) 0.77
FLT3 internal tandem duplication and FLT3-D835 mutation in 80 AML patients categorized into cytogenetic risk groups. Postepy Hig Med Dosw (Online) (2010) 0.76
[Recent indications for home oxygen therapy]. Pol Merkur Lekarski (2011) 0.76
Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation. Med Oncol (2013) 0.76
No evidence for association of the polymorphisms in NLRP1 gene with type 1 diabetes in Poland. Diabetes Res Clin Pract (2011) 0.76
Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia. Contemp Oncol (Pozn) (2012) 0.75
[Gall bladder stones during pregnancy in the age of laparoscopic cholecystectomy]. Ginekol Pol (2008) 0.75
Submicroscopic genomic rearrangements change gene expression in T-cell large granular lymphocyte leukemia. Eur J Haematol (2014) 0.75
Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes. Pol Arch Med Wewn (2015) 0.75
[Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net]. Przegl Lek (2010) 0.75
Endovascular Aneurysm Repair or Open Aneurysm Repair for the Treatment of Abdominal Aortic Aneurysm - The Latest Update. Pol Przegl Chir (2016) 0.75
Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells. Acta Haematol (2013) 0.75
[Systemic mastocytosis]. Pneumonol Alergol Pol (2005) 0.75
[The role of thrombin activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in obesity]. Pol Arch Med Wewn (2005) 0.75
Cabot rings as a result of severe dyserythropoiesis in a dog. Vet Clin Pathol (2008) 0.75
Juvenile xanthogranuloma with clonal proliferation in the bone marrow. J Pediatr Hematol Oncol (2012) 0.75
Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population. Folia Neuropathol (2015) 0.75
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials. Eur J Haematol (2013) 0.75
Polymorphisms in the interferon-induced helicase (IFIH1) locus and susceptibility to Addison's disease. Clin Endocrinol (Oxf) (2013) 0.75
[Prevalence of TT virus in patients with hepatitis B,C and hepatitis of unknown etiology]. Med Dosw Mikrobiol (2002) 0.75
Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS). Int J Hematol (2014) 0.75
Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome. J Invest Dermatol (2013) 0.75